Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > The ANSM’s involvement in the “Joint Actions” of the “EU for Health” program

https://ansm.sante.fr/page/limplication-de-lansm-dans-les-joint-actions-du-programme-lue-pour-la-sante#:~:text=L’ANSM%20collabore%20%C3%A0%208,au%20sein%20des%207%20autres.&text=Lanc%C3%A9e%20le%201er%20novembre,est%20pilot%C3%A9e%20par%20l’ANSM.

Ryan McArthur 3 March 2025 All news
  • ← ‘European Union for Health’: ANSM involved in 8 joint actions
  • New clinical trial map launched in the EU →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • New clinical trial map launched in the EU
  • The ANSM’s involvement in the “Joint Actions” of the “EU for Health” program
  • ‘European Union for Health’: ANSM involved in 8 joint actions
Copyright © 2018 - Pharmya - Legal terms - Quality Policy